CDCTF(CDCTF)
CDCTF
No analyst ratings available
No analyst price targets available for CDCTF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $41.89B | $44.04B | $43.99B | $43.84B | $44.63B |
| Low | $41.84B | $43.34B | $43.60B | $43.46B | $44.25B |
| High | $41.94B | $44.73B | $44.37B | $44.22B | $45.02B |
| EBITDA Avg | $14.35B | $15.08B | $15.07B | $15.01B | $15.29B |
| Low | $14.33B | $14.84B | $14.93B | $14.88B | $15.15B |
| High | $14.37B | $15.32B | $15.20B | $15.14B | $15.42B |
| EBIT Avg | $12.79B | $13.44B | $13.43B | $13.38B | $13.63B |
| Low | $12.77B | $13.23B | $13.31B | $13.27B | $13.51B |
| High | $12.81B | $13.66B | $13.55B | $13.50B | $13.74B |
| Net Income Avg | $61M | $58M | $57M | $57M | $55M |
| Low | $60M | $58M | $56M | $56M | $54M |
| High | $62M | $59M | $57M | $57M | $55M |
| EPS Avg | $292.26 | $279.21 | $270.39 | $271.29 | $262.03 |
| Low | $288.96 | $276.06 | $267.34 | $268.22 | $259.06 |
| High | $295.57 | $282.37 | $273.45 | $274.36 | $264.99 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $7.02B | $11.93B | $8.24B |
| Low | $4.48B | $7.62B | $5.26B |
| High | $9.56B | $16.25B | $11.23B |
| EBITDA Avg | $2.41B | $4.09B | $2.82B |
| Low | $1.54B | $2.61B | $1.80B |
| High | $3.28B | $5.56B | $3.85B |
| EBIT Avg | $2.14B | $3.64B | $2.52B |
| Low | $1.37B | $2.32B | $1.61B |
| High | $2.92B | $4.96B | $3.43B |
| Net Income Avg | $126M | $4.21B | $921M |
| Low | $67M | $2.23B | $488M |
| High | $185M | $6.19B | $1.35B |
| EPS Avg | $3.79 | $126.63 | $27.70 |
| Low | $2.01 | $67.09 | $14.67 |
| High | $5.57 | $186.17 | $40.72 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 | 1 / 1 |